Glucose as a prognostic factor in ovarian carcinoma (pages 1021–1027)
Donald M. Lamkin, Douglas R. Spitz, Mian M. K. Shahzad, Bridget Zimmerman, Daniel J. Lenihan, Koen DeGeest, David M. Lubaroff, Eileen H. Shinn, Anil K. Sood and Susan K. Lutgendorf
Article first published online: 20 JAN 2009 | DOI: 10.1002/cncr.24126
Nonfasting plasma glucose levels were determined for 74 patients with ovarian cancer at the time of their presurgical consultation and for 125 ovarian cancer patients in an independent validation set. Higher glucose levels were associated with significantly shorter survival time and shorter time to recurrence.